Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
In China, ALC is undergoing phase III clinical trials as a medication to alleviate paresthesia caused by diabetic peripheral neuropathy (17)
These medications improve blood sugar regulation regardless of diabetes status, offering valuable tools for metabolic health
Merck) precoated with 100 g/ml poly-D-lysine (P6407
This once-weekly injectable is effective for controlling blood sugar in type 2 diabetes and also aids in weight management by reducing appetite and increasing fullness
US$ 28.17
US$ 24.21
US$ 29.13
US$ 24.18
US$ 27.86
US$ 25.25
US$ 21.51
